Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
08/28/1991 | EP0443957A2 New 17-spiro substituted steroid compounds, process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them |
08/27/1991 | US5043326 Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredients |
08/23/1991 | CA2036847A1 Steroid products containing a spiro radical in position 17; process for preparing the same and intermediates for this process; their use as t erapeutic agents and |
08/23/1991 | CA2036774A1 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptorantagonist or a |
08/14/1991 | EP0441036A2 Quinoline derivatives, processes for their preparation, intermediates, and pharmaceutical compositions containing these derivatives |
08/07/1991 | EP0440183A1 Oxazole compounds, their production and use |
08/06/1991 | US5037817 Crystallization from polar or apolar solvents; produces two crystalline pure forms; improved stability increases shelf-life |
08/02/1991 | CA2035431A1 Oxazole compounds, their production and use |
07/30/1991 | US5036058 N-substituted aminoalkanediphosphonic acids |
07/11/1991 | WO1991009601A1 Use of inositolphosphates for preparing medicament |
07/11/1991 | WO1991009600A1 Oxipurinol salt composition for oral administration for treating hyperurecemia |
07/10/1991 | EP0436469A1 Composition and method for the treatment of osteoporosis in mammals |
07/03/1991 | EP0435362A1 Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline |
07/02/1991 | CA1285572C Di-t-butylphenol compounds |
06/28/1991 | WO1991009622A1 Radiolabeled colloid compositions, their use and process for their preparation |
06/16/1991 | WO1991009036A1 Beta-lactam derivatives |
06/16/1991 | CA2071885A1 Beta-lactam derivatives |
06/13/1991 | WO1991007992A1 Proliferative action of leukaemia inhibitory factor on satellite cells |
06/13/1991 | CA2045630A1 Proliferative action of leukaemia inhibitory factor on satellite cells |
06/11/1991 | US5023261 Acylated benzofuro[3,2-c]quinoline compounds with utility as treatments for osteoporosis |
06/04/1991 | US5021448 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist |
05/29/1991 | EP0429038A2 Xanthine oxidase inhibitor |
05/22/1991 | CN1012642B Process for preparation of sulfamoylbenzoic acid derivatives |
05/07/1991 | US5013728 Composition for treating osteoporosis and hormonal imbalance |
05/02/1991 | WO1991005802A1 Osteogenic devices |
05/02/1991 | EP0424954A1 Pharmaceutical composition for treatment of osteoporosis |
05/02/1991 | CA2042577A1 Osteogenic devices |
04/17/1991 | EP0422079A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use |
04/16/1991 | US5008283 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
04/09/1991 | CA1282702C Regimen for treating osteoporosis |
04/02/1991 | US5004750 Benzofuran and benzothoiphene derivatives, of tetrazole and anti-hyperuricemia use thereof |
03/26/1991 | US5002968 Organogermanium compound, calcium metabolism |
03/21/1991 | WO1990015586A3 Bioerodible polymers for drug delivery in bone |
03/19/1991 | CA1281648C Remedy for bone disease containing organogermanium compound |
03/13/1991 | EP0416689A2 Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors |
03/13/1991 | EP0416578A2 Protein, DNA and use thereof |
03/06/1991 | EP0415566A1 Heterocyclic compounds, processes for producing them and pharmaceutical compositions comprising them |
03/06/1991 | CN1049664A Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo (1,5-a)-1,3,5-triazines |
02/27/1991 | EP0414200A2 Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo [1,5-a]-1,3,5-triazines and a process for production thereof |
02/05/1991 | CA1279872C Cycloalkyl diphosphonic acid compounds and pharmaceutically-acceptable salts and esters thereof |
02/04/1991 | CA2021926A1 Heterocyclic compounds |
01/31/1991 | DE4020511A1 Medicaments for treating e.g. hypercalcaemia - contg. 24,25-di:hydroxy-cholecalciferol together with sesame oil for improved stability |
01/15/1991 | US4985444 Pyrazolopyridine compound and processes for preparation thereof |
01/09/1991 | EP0406279A1 Pharmaceutical preparation containing a fluoride salt |
12/19/1990 | EP0403185A2 Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals |
12/13/1990 | DE3922089A1 Neue proteine und ihre herstellung New proteins and their production |
12/12/1990 | CA2018700A1 Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals |
12/06/1990 | WO1990015586A2 Bioerodible polymers for drug delivery in bone |
12/05/1990 | EP0400499A2 Medicine containing acylaminoacid derivatives and dietetic products |
12/04/1990 | CA1277233C Kit for use in the treatment of osteoporosis |
12/03/1990 | WO1990014829A1 Lysolecithin derivatives for treating autoimmune diseases |
11/27/1990 | US4973584 Osteoporosis |
11/15/1990 | WO1990013575A1 Novel tnf-inhibit proteins and their preparation |
11/15/1990 | WO1990013292A1 Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
11/15/1990 | CA2425101A1 Tnf-inhibiting proteins and the preparation thereof |
10/31/1990 | EP0395093A1 Triphenylmethane derivatives |
10/31/1990 | EP0394429A1 Preparation for transdermal application containing gestodene. |
10/31/1990 | CN1046525A 3-substituted-2-oxindole derivatives |
10/24/1990 | EP0393936A1 3-substituted-2-oxindole derivatives as antiinflammatory agents |
10/03/1990 | EP0389765A1 Calcium antagonists |
09/26/1990 | EP0389035A1 Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
09/20/1990 | WO1990010619A1 NOVEL 1α-HYDROXYVITAMIN D2 EPIMER AND DERIVATIVES |
09/12/1990 | EP0387194A1 N-substituted aminoalkane-diphosphonic acids |
09/12/1990 | EP0386793A1 Novel 1 alpha-Hydroxyvitamin D2 epimer and derivatives |
09/12/1990 | EP0386109A1 Acceleration of bone formation with gm-csf |
09/08/1990 | WO1990010454A1 Metabolic effects of leukaemia inhibitory factor on bone |
09/08/1990 | CA2048673A1 Metabolic effects of leukaemia inhibitory factor on bone |
09/08/1990 | CA2011586A1 N-substituted aminoalkanediphosphonic acids |
09/05/1990 | CN1045106A Sulfur-containing heterocyclic compounds |
09/02/1990 | WO1990010228A1 Matrix metalloproteinase peptides: role in diagnosis and therapy |
08/29/1990 | EP0384731A2 Osteogenic growth polypeptides identified from regenerating bone marrow |
08/28/1990 | WO1990010631A1 9-substituted-8-unsubstituted-9-deazaguanines |
08/23/1990 | WO1990006313A3 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout |
08/23/1990 | WO1990006115A3 Preparations of oxypurinol and/or its alkali or alkaline earth salts |
08/23/1990 | CA2010660A1 Osteogenic growth polypeptides identified from regenerating bone marrow |
08/22/1990 | CN1044813A Calcium antagonists |
08/16/1990 | EP0382076A1 Phenylhydrazones, their preparation and medicaments and cosmetics manufactured therefrom |
08/16/1990 | DE4003844A1 Neue cyclosporin enthaltende galenische formulierungen New cyclosporin-containing pharmaceutical formulations |
08/15/1990 | CN1044656A Pyrazolopyridine compound and processes for preparation thereof |
08/08/1990 | EP0381296A1 Kit for use in the treatment of osteoporosis |
08/01/1990 | EP0379979A1 Pyrazolopyridine compounds and processes for preparation thereof |
07/26/1990 | WO1990007861A1 CHIMERIC IMMUNOGLOBULINS SPECIFIC FOR p55 TAC PROTEIN OF THE IL-2 RECEPTOR |
07/18/1990 | CN1043875A Novel 1 l-2 receptor-specific human immunoglobins |
07/04/1990 | EP0376197A1 Sulfur-containing heterocyclic compounds |
07/03/1990 | US4939131 Certain cycloalkane-1,1-diphosphonic acids and derivatives thereof having the ability to treat diseases associated with abnormal calcium and phosphate metabolism |
06/28/1990 | WO1990006950A1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
06/27/1990 | EP0375438A2 Recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
06/14/1990 | WO1990006313A2 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout |
06/14/1990 | WO1990006115A2 Preparations of oxypurinol and/or its alkali or alkaline earth salts |
06/13/1990 | DE3839825A1 Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze Solid dispersions containing alkaline earth oxypurinol and / or its alkali metal or alkaline |
06/12/1990 | US4933329 Bis-S-alkylbenzene derivatives |
06/05/1990 | US4931548 Heterodimer form of transforming growth factor-beta |
05/31/1990 | DE3839826A1 Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikaemie und gicht Alkali metal and alkaline earth metal salts of oxypurinol in amorphous or crystalline form as a means for the treatment of hyperuricemia and gout |
05/30/1990 | EP0370220A1 Gestode composition for transdermal application |
05/16/1990 | CN1042075A Medicines for transcortical application containing steroidhormonen |
05/03/1990 | WO1990004403A1 Treatment of hypertension |
05/03/1990 | WO1990004402A1 Treatment of osteoporosis |
05/03/1990 | WO1990004397A1 Preparation for transdermal application containing gestodene |
05/01/1990 | US4921697 IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone |
04/25/1990 | EP0365064A1 Substituted aromatic compounds having an action on the central nervous system |